BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9629248)

  • 1. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW; Ren SG; Melmed S
    Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
    Shimon I; Yan X; Ray DW; Melmed S
    J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
    Bousquet C; Melmed S
    J Biol Chem; 1999 Apr; 274(16):10723-30. PubMed ID: 10196143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
    Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
    Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
    Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
    Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C; Ray DW; Melmed S
    J Biol Chem; 1997 Apr; 272(16):10551-7. PubMed ID: 9099700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells.
    Jenab S; Morris PL
    Endocrinology; 1998 Apr; 139(4):1883-90. PubMed ID: 9528974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S; Conn PM; Melmed S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4170-8. PubMed ID: 8923879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.
    Mynard V; Guignat L; Devin-Leclerc J; Bertagna X; Catelli MG
    Endocrinology; 2002 Oct; 143(10):3916-24. PubMed ID: 12239103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines.
    Li QL; Jansen E; Friedman TC
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):143-52. PubMed ID: 10630414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary cytokine network.
    Kariagina A; Romanenko D; Ren SG; Chesnokova V
    Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.
    Stefana B; Ray DW; Melmed S
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12502-6. PubMed ID: 8901611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis.
    Ware CB; Kariagina A; Zonis S; Alon D; Chesnokova V
    FEBS Lett; 2005 Aug; 579(20):4465-9. PubMed ID: 16081071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V; Melmed S
    Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.